All posts by PIER MARIA FORNASARI

PIER MARIA FORNASARI
2019-08-22

Pfizer invests half billion dollars to advance state-of-the-art gene therapy facility in Sanford, North Carolina

Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility is anticipated to support Pfizer’s continuing investment in gene therapy research and development, similar to Pfizer’s Chapel Hill and Kit Creek, North Carolina research and development sites. This facility would

Read More

No Comments InGENE THERAPY RARE DISEASES
PIER MARIA FORNASARI
2019-08-22

NGen Supercluster starts with project to scale the production of treatments for cancers and rare diseases

iVexSol’s project will tackle the cost and shortages of these treatments through high-volume production solution Source Innovation, Science and Economic Development Canada Through the Innovation Superclusters Initiative, the Government of Canada is taking immediate and targeted action to build on Canada’s existing strengths to help our companies and their workers get ahead in the global

Read More

No Comments InREGENERATIVE MEDICINE
PIER MARIA FORNASARI
2019-08-22

Precision Medicine Trials and Molecular Testing Guidelines Expand to Reach More Patients

The Lung Cancer Master Protocol (Lung-MAP), a large precision medicine umbrella trial supported by the National Cancer Institute (NCI) and their partners, has opened the trial to include advanced-stage patients with all non–small cell lung cancers (NSCLCs). To accommodate these new trial patients, the NCI has also made further changes to the trial’s protocol.  The

Read More

No Comments InPRECISION MEDICINE
PIER MARIA FORNASARI
2019-08-22

Gene Therapy Market Research Explores The Key Success Factors And Business Opportunities Including Key Players Forecast Till 2026

Source Transparency Market Research Gene Therapy Market – Snapshot The global gene therapy market is expanding at an exponential pace due to promising therapeutic outcomes of gene therapy, high prevalence and rise in incidence of cancer, and large number of clinical research pipeline products. In terms of revenue, the market was valued at US$ 17.0

Read More

No Comments InGENE THERAPY RARE DISEASES
PIER MARIA FORNASARI
2019-08-21

Now Available: ARM’s Searchable, Downloadable Database of Near-Term Anticipated RM/AT Data Readouts and Other Clinical Events

This new resource provides clear, simplified information on indication-, technology-, or company-specific upcoming data readouts and other clinical events. ARM has carefully curated all entries to ensure they fall within our narrowly defined criteria for regenerative medicines, and includes many milestones which are not reported in other clinical trial datasets, including anticipated product approvals. Currently, the database includes 188 anticipated events and includes a search-and-download function, and

Read More

No Comments InREGENERATIVE MEDICINE
PIER MARIA FORNASARI
2019-08-21

Researchers turn plastic water bottles into prosthetic limbs

Artificial limbs made out of plastic water bottles could save healthcare providers millions of pounds and help tackle pollution at the same time. An expert at De Montfort University Leicester (DMU) has successfully manufactured the first-of-its-kind prosthetic limb socket made from recycled plastic bottles. Dr K Kandan, senior lecturer in Mechanical Engineering at DMU, found he could

Read More

No Comments InPROSTHETIC LIMB
PIER MARIA FORNASARI
2019-08-21

Stem cell-based bone and dental regeneration: a view of microenvironmental modulation

In modern medicine, bone and dental loss and defects are common and widespread morbidities, for which regenerative therapy has shown great promise. Mesenchymal stem cells, obtained from various sources and playing an essential role in organ development and postnatal repair, have exhibited enormous potential for regenerating bone and dental tissue. Currently, mesenchymal stem cells (MSCs)-based

Read More

No Comments InREGENERATIVE MEDICINE